More

    Europe Markets

    2011-13976 | CFTC

    Federal Register, Volume 76 Issue 109 (Tuesday, June...

    Voxzogo | European Medicines Agency (EMA)

    OverviewVoxzogo is a medicine for treating achondroplasia in patients aged 4 months and older whose bones are still growing.Achondroplasia is an inherited disease...

    Idefirix | European Medicines Agency (EMA)

    OverviewIdefirix is a medicine used to prevent the body from rejecting a newly transplanted kidney.Idefirix is used before transplantation in adults who have...

    Scintimun | European Medicines Agency (EMA)

    OverviewThis is a summary of the European Public Assessment Report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP)...

    Enjaymo | European Medicines Agency (EMA)

    OverviewEnjaymo is a medicine for treating haemolytic anaemia (excess breakdown of red blood cells) in adults with cold agglutinin disease (CAD).CAD is a...

    Emadine | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP)...

    Polivy | European Medicines Agency (EMA)

    OverviewPolivy is a cancer medicine used to treat adults with diffuse large B-cell lymphoma (DLBCL, a blood cancer affecting white blood cells):in patients...

    Buvidal | European Medicines Agency (EMA)

    OverviewBuvidal is a medicine used to treat dependence on opioid (narcotic) drugs such as heroin or morphine.Buvidal is used in adults and adolescents...

    Sivextro | European Medicines Agency (EMA)

    OverviewSivextro is an antibiotic used in adults, adolescents and children to treat acute (short-term) bacterial infections of the skin and skin structures (tissue...

    Prevenar 13 | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Prevenar 13. It explains how the Committee for Medicinal Products for...

    Constella | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Constella. It explains how the Committee for Medicinal Products for Human...

    Humira | European Medicines Agency (EMA)

    OverviewHumira is a medicine that acts on the immune system and is used to treat the following conditions:plaque psoriasis, a disease causing red,...

    EMA qualifies first artificial intelligence tool to diagnose inflammatory liver disease (MASH) in biopsy samples

    EMA’s human medicines committee (CHMP) has issued the first Qualification Opinion (QO) on an innovative development methodology based on artificial intelligence (AI). The...

    Tenofovir disoproxil Zentiva | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Tenofovir disoproxil Zentiva. It explains how the Agency assessed the medicine...

    Pomalidomide Krka | European Medicines Agency (EMA)

    OverviewPomalidomide Krka is a cancer medicine used to treat multiple myeloma (a cancer of the bone marrow). It is used in combination with...

    Namuscla | European Medicines Agency (EMA)

    OverviewNamuscla is a medicine used to treat symptoms of myotonia (muscle stiffness) in patients with non-dystrophic myotonic disorders, a group of inherited muscle...

    Awiqli | European Medicines Agency (EMA)

    OverviewAwiqli is a medicine used to treat adults with diabetes. It contains the active substance insulin icodec, a long-acting insulin.Expand sectionCollapse sectionHow is...